Version 11.3 by Sarantis Dimitriadis on 2023/12/08 12:59
Hide last authors
Sarantis Dimitriadis 5.2 1 (% class="western" lang="en-GB" style="text-align:justify" %)
2 (% lang="en-US" %)**End user:** A person who ultimately uses or is intended to ultimately use the product, service or process. In living lab project, end user is defined as a primary study participant who voluntarily participates research after giving informed consent to be the subject of the research.
3
4 (% class="western" lang="en-GB" style="text-align:justify" %)
5 (% lang="en-US" %)**Living lab research infrastructure end user:** A person or organization who(%%) (% lang="en-US" %)purchases or uses living lab research infrastructure services to conduct a specific contract based research and development activity (often focusing on specifically defined end user group). Living lab research infrastructure end user can also be study participant (a.k.a. end user), if living project is focusing on developing living lab services and infrastructure.
6
7 (% class="western" lang="en-GB" style="text-align:justify" %)
8 (% lang="en-US" %)End users can be classified to non-professional and professional groups. Typical non-professional and professional end-user groups in health and wellbeing includes the following:
9
Sarantis Dimitriadis 5.11 10 :
Sarantis Dimitriadis 5.10 11
Sarantis Dimitriadis 5.2 12 * (((
13 (% lang="en-US" %)**Non-professional end users:**
14
15 * (% lang="en-US" %)**Consumers: **Those who buy goods or services for their own use.
16
17 * (% lang="en-US" %)**Public health and social service clients: **Those who use public services.
18 )))
19
Sarantis Dimitriadis 5.11 20 :
Sarantis Dimitriadis 5.10 21
Sarantis Dimitriadis 5.2 22 * (((
23 (% lang="en-US" %)**Professional end users**
24
25 * (% lang="en-US" %)**Health professionals and managers:** A person providing health care treatment and advice based on formal training and experience. Also known as healthcare professional or healthcare worker.
26
27 * (% lang="en-US" %)**Social care workers and managers:** Those providing the practical support to help people cope with the day-to-day business of living based on formal training and experience.
28
29 * (% lang="en-US" %)**Policy and decisions makers:** Those responsible for making policies and decisions at local, regional, national or international level.
30 )))
31
Sarantis Dimitriadis 5.11 32 :
Sarantis Dimitriadis 5.10 33
Sarantis Dimitriadis 5.2 34 (% class="western" lang="en-GB" %)
35 (% lang="en-US" %)**Business-to-Business Customer (B2B):** B2B-customer is an organization that purchases living lab services from a living lab. B2B-customers can be classified to private, public, education/ research, civil society organizations and networks/cluster groups as follows:
36
Sarantis Dimitriadis 5.11 37 :
Sarantis Dimitriadis 5.10 38
Sarantis Dimitriadis 5.2 39 * (((
40 (% lang="en-US" %)**Private sector organizations: **(business developers and researchers)
41
42 * (% lang="en-US" %)Tangible equipment and device manufactures
43
44 * (% lang="en-US" %)Health and social service providers
45
46 * (% lang="en-US" %)e-health, IT system and digital technology providers
47
48 * (% lang="en-US" %)Wellbeing and wellness service providers
49
50 * (% lang="en-US" %)Pharmaceutical companies
51 )))
52
Sarantis Dimitriadis 5.11 53 :
Sarantis Dimitriadis 5.10 54
Sarantis Dimitriadis 5.2 55 * (((
56 (% lang="en-GB" %)
57 (% lang="en-US" %)**Public sector organizations:**
58
59 * (% lang="en-US" %)**Local level: **Municipals, cities and other local level public organizations providing e.g. health and social services such as primary health care.
60
61 * (% lang="en-US" %)**Regional level: **e.g.** **Regional** **hospitals providing secondary and tertiary care,** **councils, parliaments, and governments as well as other administrative organizations operating at regional level.
62
63 * (% lang="en-US" %)**National level: **Government agencies, departments or temporary pointed working groups responsible for the specific functions such as health and social services.
64
65 * (% lang="en-US" %)**International level: **European commission departments and agencies as well as other organizations operating at international and transnational level.
66
67 * (% lang="en-US" %)**Public funder:** Government or other European, national, regional or local public institutions who is providing public funding for a specific living lab living lab research project via call for application process.
68 )))
69
Sarantis Dimitriadis 5.11 70 :
Sarantis Dimitriadis 5.10 71
Sarantis Dimitriadis 5.2 72 * (((
73 (% lang="en-GB" %)
74 (% lang="en-US" %)**Education and research organizations:**
75
76 * (% lang="en-US" %)**Higher education institutes:** Universities and Universities of Applied Sciences
77
78 * (% lang="en-US" %)**Other educational institutes** covering early childhood, primary, secondary and tertiary education
79
80 * (% lang="en-US" %)**Public research institutions/organizations** such as technical research centers and government laboratories.
81
82 * (% lang="en-US" %)**Private research organizations** such as technology and innovation centers
83 )))
84
Sarantis Dimitriadis 5.11 85 :
Sarantis Dimitriadis 5.10 86
Sarantis Dimitriadis 5.2 87 * (((
88 (% lang="en-GB" %)
89 (% lang="en-US" %)**Civil society organizations:**
90
91 * (% lang="en-US" %)Non-governmental organizations (NGO) and nonprofit entities operating at international, national, regional or local level.
92 )))
93
Sarantis Dimitriadis 5.11 94 :
Sarantis Dimitriadis 5.10 95
Sarantis Dimitriadis 5.2 96 * (((
97 (% lang="en-GB" %)
98 (% lang="en-US" %)**Networks and clusters:**
99
100 * (% lang="en-US" %)Company cluster organizations and company networks
101 * (% lang="en-US" %)International, national, regional and local networks
102 )))
103
Sarantis Dimitriadis 5.9 104 :
105
Sarantis Dimitriadis 5.2 106 (% class="western" lang="en-GB" %)
Sarantis Dimitriadis 11.3 107 Classification approaches of non-professional end users commonly acting as a primary study participant in a health and wellbeing living lab research project.
Sarantis Dimitriadis 5.2 108
Sarantis Dimitriadis 10.1 109 (% style="margin-left:auto; margin-right:auto; width:1694px" %)
Sarantis Dimitriadis 6.1 110 |(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)**Age groups**
Sarantis Dimitriadis 10.1 111 |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
Sarantis Dimitriadis 5.5 112 (% lang="en-US" %)Specific age range
Sarantis Dimitriadis 10.1 113 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
Sarantis Dimitriadis 5.2 114
Sarantis Dimitriadis 10.1 115 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
Sarantis Dimitriadis 5.2 116 (% class="western" %)
117
Sarantis Dimitriadis 10.1 118 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
Sarantis Dimitriadis 5.2 119 (% class="western" %)
120
121 )))
Sarantis Dimitriadis 10.1 122 |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Adolescents|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Older Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)General Population
Sarantis Dimitriadis 6.1 123 |(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adolescents Health status (disease, disorder or disability)**
Sarantis Dimitriadis 10.1 124 |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
Sarantis Dimitriadis 5.2 125 (% class="western" lang="en-GB" %)
Sarantis Dimitriadis 5.5 126 (% lang="en-US" %)Healthy
Sarantis Dimitriadis 10.1 127 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:153px" %)(((
Sarantis Dimitriadis 5.2 128 (% class="western" lang="en-GB" %)
Sarantis Dimitriadis 6.1 129
Sarantis Dimitriadis 10.1 130 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:153px" %)(((
Sarantis Dimitriadis 5.2 131 (% class="western" lang="en-GB" %)
Sarantis Dimitriadis 6.1 132
Sarantis Dimitriadis 10.1 133 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
Sarantis Dimitriadis 5.2 134 (% class="western" lang="en-GB" %)
Sarantis Dimitriadis 6.1 135
Sarantis Dimitriadis 5.2 136 )))
Sarantis Dimitriadis 6.1 137 |(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adults Health status (disease, disorder or disability)**
Sarantis Dimitriadis 8.1 138 |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Schizophrenia|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Multiple-Sclerosis|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Parkinson Disease
Sarantis Dimitriadis 9.1 139 |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:152px" %)Post-Stroke Patients with Moving or Linguistic Disability|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Mild Cognitive Impairment|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Sleep Disorders: e.g., Apnea, Hypopnea|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)With Disability
Sarantis Dimitriadis 10.1 140 |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Healthy with Possible Chronic Conditions|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
Sarantis Dimitriadis 6.1 141 |(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Older Adults Health status (disease, disorder or disability)**
Sarantis Dimitriadis 9.1 142 |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Parkinson Disease|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Mild Cognitive Impairment|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)With Disability
Sarantis Dimitriadis 10.1 143 |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Healthy with Possible Chronic Conditions|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
Sarantis Dimitriadis 5.2 144 (% class="western" lang="en-GB" %)
Sarantis Dimitriadis 6.1 145
Sarantis Dimitriadis 10.1 146 )))|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
Sarantis Dimitriadis 5.2 147 (% class="western" lang="en-GB" %)
148
Sarantis Dimitriadis 10.1 149 )))|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
Sarantis Dimitriadis 5.2 150 (% class="western" lang="en-GB" %)
151
152 )))
Sarantis Dimitriadis 6.1 153 |(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**General Population Health status (disease, disorder or disability)**
Sarantis Dimitriadis 8.1 154 |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="text-align:justify; vertical-align:middle" %)Ipf Patients|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Prostate Cancer|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
Sarantis Dimitriadis 5.2 155 (% class="western" lang="en-GB" %)
Sarantis Dimitriadis 6.1 156 Down Syndrome
Sarantis Dimitriadis 5.2 157 )))
Sarantis Dimitriadis 9.1 158 |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:152px" %)Chronical Diseases: e.g., Persons With Chronic Pulmonary (Copd)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Cardiological Or Other Conditions (Aphasia)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Breast Cancer Survivors|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
Sarantis Dimitriadis 5.2 159 (% class="western" lang="en-GB" %)
160
161 )))
162
Sarantis Dimitriadis 5.9 163 :
Sarantis Dimitriadis 9.1 164 :
Sarantis Dimitriadis 11.3 165 : Classification approaches of professional end users, students and organisations commonly acting as a primary study participant in a health and wellbeing living lab research project.
Sarantis Dimitriadis 5.9 166
Sarantis Dimitriadis 9.1 167 (((
168 (% style="margin-left:auto; margin-right:auto; width:1694px" %)
169 |(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Informal Caregivers**
Sarantis Dimitriadis 10.1 170 |(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %)Part of adults and citizens' group|(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %)
Sarantis Dimitriadis 9.1 171 |(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Health Care Professionals / Formal Caregivers**
172 |(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Doctors|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Social workers|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Physiotherapists|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Psychologists
Sarantis Dimitriadis 10.1 173 |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Registered nurses|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Practical nurses|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Physicians|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
Sarantis Dimitriadis 9.1 174 |(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Students**
175 |(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Medical|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Engineering|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Computer Science|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Pedagogues
176 |(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)English Literature|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Nursing|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Physiotherapy|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Social Services
Sarantis Dimitriadis 10.1 177 |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Health Care Management|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
Sarantis Dimitriadis 9.1 178 |(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Organizations**
179 |(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Hospitals|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Nursing homes|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Care homes|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Home care Organizations
180 |(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Network organizations|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Day care centers|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)
181
182
183 )))
184
185 :
186
Sarantis Dimitriadis 5.2 187 (% class="western" lang="en-GB" %)
Sarantis Dimitriadis 6.1 188 (% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in (%%)the table below(% style="page-break-before:always" %) .
Sarantis Dimitriadis 5.2 189
Sarantis Dimitriadis 1.1 190 |**Researcher expertise**|**Brief use case description**
Sarantis Dimitriadis 11.1 191 |(% style="vertical-align:middle" %)Citizen scientists, users as co-researchers|(% style="vertical-align:middle" %)User empowerment, training, design, analysis and implementation of strategies and methodologies for user engagement and for raising awareness and generating citizen participation.
192 |(% style="vertical-align:middle" %)Computer, technology scientists|(% style="vertical-align:middle" %)Developing systems/tools/ technologies, testing and evaluating an ICT tool, prototype and real-life testing, computer vision & AI, Virtual Reality & Augmented Reality, Cybersecurity.
193 |(% style="vertical-align:middle" %)Data scientists|(% style="vertical-align:middle" %)Collecting, analysing and interpreting digital data, such as data analytics in healthcare and digital patient recordings (how patient information recording process is managed and utilized during the intervention by using digital tools in simulated situations).
194 |(% style="vertical-align:middle" %)Rehabilitation (physical, cognitive) experts|(% style="vertical-align:middle" %)Physiology, physiotherapy, occupational health research, rehabilitation and prevention. Cognitive diseases assistive technology, neuromuscular rehabilitation assistive technology.
195 |(% style="vertical-align:middle" %)UX research and assessment experts|(% style="vertical-align:middle" %)Developing the process for user experience design (UXD, UED, or XD) supporting user behaviour through usability, usefulness, and desirability provided in the interaction with a product or service, addressing all aspects as perceived by users with a focus on the quality of the user experience. Studying and experimenting the best practices for UI/UX and evaluating user’s experience in different situations and while using different tools.
196 |(% style="vertical-align:middle" %)Clinical expertise researchers|(% style="vertical-align:middle" %)(Doctors, nurses, healthcare workers, specialists, physiotherapists etc.), conducting research of healthcare services and practices, research on symptomatology or epidemiology of a disease, analysis of clinical effects of research performed in the study, e.g., via real life testing.
197 |(% style="vertical-align:middle" %)Policymakers|(% style="vertical-align:middle" %)Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making.
198 |(% style="vertical-align:middle" %)Biomedical researchers|(% style="vertical-align:middle" %)Studying biochemical and physiological functions, investigating how the human body works with the aim of finding new ways to improve health. Biomedical engineering knowledge (Home hospitalization, Transitional Care, Multifunctional interaction), as well as digital biomarkers analysis (e.g., for cognitive state).
199 |(% style="vertical-align:middle" %)Business developers|(% style="vertical-align:middle" %)Studying the product-market fit, matching a solution with a societal need, learning about the user acceptance of products and services, as well as about potential products to develop, willingness to pay, business model and ideal route to market.
200 |(% style="vertical-align:middle" %)Innovation and design management researchers|(% style="vertical-align:middle" %)Ecosystem and innovation management research, social network analysis. Evaluating how health and wellbeing ecosystem operates between different actors at local, regional, national and international level, including also scaling and commercialization.
201 |(% style="vertical-align:middle" %)Accessibility design experts|(% style="vertical-align:middle" %)Validating accessible architectonics and escape route models with VR experiment and real-life simulations.
202 |(% style="vertical-align:middle" %)Ergonomics and safety experts|(% style="vertical-align:middle" %)Implementation and validation of ergonomic technologies/services to support workers and system performance, promoting ergonomics in working environments, improving both health/well-being and productivity, while avoiding occupational hazards.
203 |(% style="vertical-align:middle" %)Organizational studies experts|(% style="vertical-align:middle" %)Co-creation, experimentation, organizational research, experts by experience / pier support included. Evaluation how multistakeholder collaboration and co-creation is done and how effective it is. Evaluates experimentations and experimentation culture. How users are involved into these processes.
204 |(% style="vertical-align:middle" %)Neuroscientists|(% style="vertical-align:middle" %)Focusing on the brain and its impact on behaviour and cognitive functions (cognitive neuroscience, EEG-based BMI research, protocol / paradigm testing, study framework evaluation).
205 |(% style="vertical-align:middle" %)Psychologists (clinical, social, developmental, neuro)|(% style="vertical-align:middle" %)Studying the behaviour and the mental wellbeing of participants, conducting psychometrics evaluation and real-life setting experimentation/observation/real life testing.
206 |(% style="vertical-align:middle" %)Social workers/researchers|(% style="vertical-align:middle" %)Conducting an investigation in accordance with the scientific methods and tools, studying the impact of new care models and/or care innovations on society, developing models for a caring and inclusive society.
207 |(% style="vertical-align:middle" %)Sport science experts|(% style="vertical-align:middle" %)Experimenting novel training methods, and their effectiveness in various dimensions such as safety, engagement, and physical capabilities. Studying the impact of physical movements in various functions and wellbeing features.
208 |(% style="vertical-align:middle" %)Communication studies experts|(% style="vertical-align:middle" %)Defining written, oral, visual and digital communication within a certain workplace. Evaluating (multi professional) healthcare team collaboration, communication and debriefing in various healthcare situations in simulated environments (especially in Simulation lab).
209 |(% style="vertical-align:middle" %)Performing arts experts|(% style="vertical-align:middle" %)Creative health improvement (e.g., for cognitive decline) through music and dance (example: redesigning public spaces into healthy spaces: test and validate Smart methodologies, products and services through folk dance).
210 |(% style="vertical-align:middle" %)Pedagogues/educators|(% style="vertical-align:middle" %)Evaluating different pedagogical approaches and their impact learning performance (especially in Simulation lab).
211 |(% style="vertical-align:middle" %)Applied economics experts|(% style="vertical-align:middle" %)Evaluating cost and performance in different healthcare processes, situations and public health.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101007990

Copyright © 2021 VITALISE Project